Chapter 3

Where the Cash Goes

The two acts before this one built a business that earns roughly double its peers' margins out of a single Americas engine — a position written into the wall of institutional buildings and slow to dislodge. This act follows the money that engine throws off. In 2025 Allegion generated more free cash flow than in any year of its public life — $685.7 million — and handed less of it back to shareholders than it had the year before [1]. Dividends plus buybacks fell from $387.0 million in 2024 to $255.3 million in 2025. That is not a contradiction. It is the whole capital story compressed into a single line, and the rest of this chapter unpacks where the difference went.

Earnings that turn into cash

Start with the quality of the cash itself, because everything downstream depends on it being real. Allegion's reported profit converts to cash with almost no leakage. Operating cash flow has exceeded net earnings in every year of the window and the gap has widened, not narrowed: operating cash flow was 1.11 times net earnings in 2023, 1.13 times in 2024, and 1.22 times in 2025 [2]. After capital spending, free cash flow of $685.7 million was still 1.07 times the $643.8 million of net earnings [3]. A company earning more accounting profit than the cash it collects is where accounting problems hide; Allegion has the opposite signature.

Source: FY2025 Annual Report (Form 10-K), Consolidated Statements of Cash Flows [4].

Two mechanics drive that conversion. The first is that the model barely consumes capital: 2025 capital expenditure was $98.1 million, or 2.4% of revenue, against depreciation and amortization of $133.2 million [5]. When a business's non-cash charges run above the cash it reinvests, reported earnings understate the cash the operation releases. The second is that working capital is close to neutral: in 2025 receivables actually released $23.7 million of cash even as revenue grew 7.8%, and the accounts-payable and inventory movements roughly offset [6].

Source: FY2025 Annual Report (Form 10-K), Consolidated Statements of Cash Flows [7].

One line resists the clean reading, and it is worth pausing on because it looks like a warning sign and is not. Inventory on the balance sheet jumped 22.7%, from $423.0 million to $519.0 million, far ahead of 7.8% revenue growth — the kind of divergence that often flags demand that management expected and did not get [8]. But the cash-flow statement shows inventories drew only $38.9 million of cash [9], and the acquisition note shows businesses bought during the year arrived carrying $38.9 million of net working capital [10]. The balance-sheet build is largely stock that came in with the deals, not an organic ramp against soft orders. Which points at the real subject of this chapter: the deals.

The largest line the numbers hide

There is a trap in the standardized data for this company, and any reader modeling Allegion from a data feed will fall into it. The canonical figures record cash spent on acquisitions as $0.00 in 2022, 2023, 2024 and 2025 — implying a business that makes no acquisitions and returns all its cash. The audited cash-flow statement says the opposite. The line "Acquisition of and equity investments in businesses, net of cash acquired" shows outflows of $31.7 million in 2023, $137.2 million in 2024, and $592.2 million in 2025 [11], and the 2022 accounts record $923.1 million of cash paid for a single deal [12]. In 2025, Allegion used $685.5 million in investing activities; with capital spending only $98.1 million of that, the remainder is deals [13]. Acquisitions are not a footnote to this company's capital allocation. In three of the last four years they are the single largest discretionary use of cash.

That correction is exactly what explains the drop the chapter opened with. Buybacks plus dividends fell from 66.4% of free cash flow in 2024 to 37.2% in 2025 [14]. Read against a $0 acquisition line, that looks like cash piling up unspent. Read against a $592.2 million acquisition line, it is straightforward: free cash flow hit a record, the dividend rose, and buybacks were cut to $80 million to help fund the largest deal year in the company's history. The falling payout ratio is not idle cash. It is the acquisition program showing up as a claim on the same dollars.

Sources: FY2025 Annual Report (Form 10-K), Consolidated Statements of Cash Flows [15]; FY2022 10-K, MD&A Liquidity (2022 acquisition) [16].

An acquirer, accelerating

The shape of the bars matters as much as their height. In 2022 Allegion made one large, debt-financed purchase — the $923.1 million Stanley Access Technologies deal, the automatic-entrance business it bought from Stanley Black and Decker and folded into the Americas segment [17]. Then 2023 was quiet, at $31.7 million. What followed is the pattern to watch: a rising cadence of smaller "bolt-on" deals — five in 2024 for $137.2 million, then nine in 2025 for aggregate consideration of roughly $631.6 million, of which $592.2 million was cash out the door [18]. A bolt-on is a small company bought to slot into an existing line rather than to open a new business; the 2025 slate ran from a U.S. multifamily access-control provider to U.K. and Australian hardware makers, led by ELATEC, a German electronics-and-access-technology manufacturer bought for €327.9 million (about $386.5 million) and placed in the International segment [19].

On the earnings call, management framed the year the same way the cash flow does: "$630 million was used for bolt-on acquisitions," alongside "a twelfth consecutive annual dividend increase," with the stated priority "towards profitable growth" [20]. The order of that sentence is worth keeping: deals first, dividend second.

The program is funded off a balance sheet deliberately kept with room to spare. Net debt has hovered near $1.5–1.8 billion for years, and Allegion manages leverage to an investment-grade target. Its own history slide shows net debt at 1.6 times adjusted EBITDA at the end of 2024, having spiked to 2.5 times in 2022 for the Access Technologies deal and de-levered within two years [21]; management put the ratio at 1.6 times again at the end of 2025, "which supports continued capital deployment" [22].

Sources: May 2025 Investor Presentation, Leverage Management (2019–2024) [23]; Q4 FY2025 earnings call (2025 year-end 1.6x) [24].

Two moves at the end of 2025 read as preparation for the next wave rather than a pause. Allegion enlarged its revolving credit line from $750 million to $1.0 billion and pushed the maturity out to 2030, using it to retire a term loan; its senior notes are laddered across 2027, 2029, 2032 and 2034, so there is no near-term refinancing wall [25]. A larger revolver on a lightly levered balance sheet is dry powder held ready.

The dividend and the residual

Against the acquisitions, the two forms of direct shareholder return look small and play different roles. The dividend is the reliable one. Allegion has raised it for twelve straight years, taking the quarterly rate to $0.55 for 2026 from $0.51, a 7.8% step, and paid $175.3 million in 2025 [26]. But the dividend has grown more slowly than the cash behind it — cash dividends rose from $143.9 million in 2022 to $175.3 million in 2025, roughly 7% a year, while free cash flow compounded far faster — so the share of cash paid out as dividends has been drifting down, not up.

Buybacks are the flex variable, and 2025 shows how far down the queue they sit. Allegion spent $80 million repurchasing about 0.6 million shares and bought none at all in the fourth quarter; $160 million remained available under a $500 million authorization first set in 2023 [27]. Management describes the buyback's job narrowly: "at a minimum, we intend to offset the creep from share-based compensation" [28]. That is close to what happened — 0.4 million shares were issued into equity plans and 0.6 million bought back, leaving ordinary shares outstanding down fractionally at 86.1 million [29]. Diluted share count has fallen only about 1.9% across three years — a slower reduction than the roughly 2.7% median cut at the four listed peers in 2025, as reported across the peer set. Per-share compounding from repurchases is, for now, a rounding factor; the capital that could drive it is going to deals instead.

What the balance sheet is absorbing

Every acquisition leaves a residue on the balance sheet, and after two busy years Allegion's is visibly heavier. Goodwill rose 28% in a single year, from $1,489.4 million to $1,912.4 million, and now stands at 37% of the company's $5,223.7 million of total assets [30]. Add the $826.0 million of net acquired intangibles and the two soft-asset lines together — $2,738.4 million — exceed the company's entire $2,067.6 million of shareholders' equity [31]. This is what a bought-growth strategy looks like carried on the books: the accounting value of the enterprise is increasingly the price paid for other companies.

Source: FY2025 Annual Report (Form 10-K), Consolidated Balance Sheets [32].

Almost all of the fresh goodwill landed in one place. International goodwill roughly doubled, from $303.5 million to $631.3 million, while the Americas figure rose only modestly [33]. That is the mechanical proof of a point the richest corner left open: International revenue growth is bought, not earned. Total assets in the International segment jumped from $1,146.0 million to $1,886.1 million on the deal wave [34]. And what is being bought enters at a fraction of the home margin: the International segment earned a 9.0% operating margin in 2025 against the Americas' 27.9% [35]. Allegion is redeploying cash earned at 28 cents on the revenue dollar into businesses that, so far, earn nine.

Three facts bound how much a reader should trust this program before its returns are visible. First, it is too young to judge on results: the nine deals closed in 2025 contributed only $93.0 million of revenue and $4.7 million of pre-tax earnings from their closing dates to year-end [36]. Second, there is a base rate, and it is not spotless: the International segment still carries $573.6 million of accumulated goodwill impairment from an earlier era of deals — a write-off close to a full year of today's free cash flow — even though nothing has been impaired since 2023 [37]. Allegion's history of buying international growth includes at least one large sum that did not earn its keep. Third, the cost of running the machine is treated as if it were not a running cost. Acquisition and integration expenses recur every year — $21.0 million in 2023, $11.4 million in 2024, $14.6 million in 2025 — booked in selling and administrative expense, and Allegion adds them back to the adjusted-earnings, adjusted-EBITDA and available-cash-flow measures it features in its reporting [38]. For a company doing nine deals a year, those "one-off" costs are a permanent feature of the operating model, so the adjusted numbers sit structurally above the audited ones — a gap the record chapter revisits where those same adjusted metrics drive management pay.

None of this is a reporting red flag. PwC signed a clean opinion on both the accounts and internal controls, with a single critical audit matter on revenue recognition and no restatement [39], and the cash conversion behind the numbers is genuine [40]. The point is narrower and more useful: Allegion is not the all-cash-returning compounder its headline free cash flow suggests. It is a cash machine that has chosen to spend its surplus buying lower-margin growth, on an accelerating schedule, with the returns still unproven and a mixed record behind it. Whether that redeployment pays — and whether the company can operate what it is buying — is the swing factor in per-share value from here. It also lands the story in a suggestive place: the one segment now absorbing the most capital is the same one that houses the company's only recent stumble, which is where the record itself comes up for examination.